On November 18, 2022, Jason, the International PR Manager for 2FIRSTS, a global professional e-cigarette industry media, held a discussion with Craig Copland, the Electronic Cigarette Group Leader of the Medical and Healthcare Products Regulatory Agency (MHRA) and the Market Access Department in the UK, regarding the issues surrounding the entry of Chinese e-cigarette products into the UK market after the implementation of the new national standard.
The potential advantages of electronic cigarettes.
The electronic cigarette division led by Copland falls under MHRA's "healthcare, quality and access group," while heated tobacco products and traditional tobacco products are overseen by Public Health England (PHE). Copland explains that this means electronic cigarettes have a greater advantage than other tobacco products. For example, electronic cigarette products can be advertised as "nicotine replacement products" or "smoking cessation products"; when doctors prescribe for smokers, they can also write electronic cigarette products, but the threshold for obtaining such medical electronic cigarette products is extremely high. "One of the major tasks of the UK National Health Service (NHS) is to help smokers quit smoking, and electronic cigarettes are one of the tools to quit smoking," says Copland.
Compliance for overseas expansion requires joint efforts from both parties.
Copland stated that his department focuses mainly on obtaining market access certificates for electronic cigarette products, regulating electronic cigarette products, and providing publicly available compliance data on its official website for manufacturers to reference. He also pointed out that Chinese products currently face compliance issues in the UK market, with 25% of Chinese products entering the UK market not complying with regulations, especially for those popular products.
Jason explained that one of the hottest-selling products in the UK, Elux, is often counterfeit. The counterfeiting of Elux-registered trademarks is a typical case, but with the implementation of the new national standard policy and the stricter regulations on e-cigarettes in China, similar situations will no longer occur.
Copland suggests that relevant departments from China and the UK should collaborate on the admission of electronic cigarettes. This is because the UK's border inspection departments often cannot determine whether imported electronic cigarettes are compliant and legal, and they require certification from the MHRA. Even if illegal products are identified, the MHRA cannot determine their source. Therefore, if the MHRA can align its inspection standards with Chinese regulatory agencies and screen out non-compliant products before takeoff, it would be highly efficient for them to enter the UK market. Copland says that the MHRA is willing to provide relevant information to Chinese departments to assist Chinese companies in compliance and growth.
Finally, Copland expressed a sincere hope to engage in extensive cooperation with Chinese counterparts and acknowledged the role of 2FIRSTS as a bridge for data and information exchange between the two parties.
Statement:
1. This article is intended solely for internal communication and discussion within the industry, and does not serve as any promotion or recommendation for any specific brands or products. 2. Smoking is harmful to health. Minors are strictly prohibited from reading this article.
This article is an original piece by 2FIRSTS Technology Co., Ltd. in Shenzhen. All copyright and usage rights belong to the company and no individual or organization can copy, reproduce, or use the content without permission. Any unauthorized use will result in legal action taken by the company.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
